ABSTRACT… Salivary Duct Carcinoma is a rare but highly aggressive tumor of the parotid gland. This tumor histologically shares the features of invasive duct cell carcinoma of breast. Here we present a case of such an advanced T4aN2M0 tumor involving overlying skin and level I and II lymph nodes which was managed by radical conservative parotidectomy followed by free radial forearm flap. Patient postoperatively received chemo radiation and is recurrence free over a period of two years. We also give a brief account of literature review regarding Salivary Duct Carcinoma and its management.
INTRODUCTION
Salivary duct carcinoma is a rare tumor accounting for 1-3% of all malignant salivary gland tumors. 1, 2 Initially, a group of malignant salivary gland tumors characterized by ductal formations and central necrosis were first described by Kleinsasser et al. in 1968 . 3 These tumors have enormous potential to invade the surrounding structures directly or through perineural and lymphatic spread. Generally the prognosis is considered poor to other less aggressive tumors of the parotid. [1] [2] [3] Few such cases have been reported previously hence biologic behavior and pathological characteristics are yet to be determined.
CASE REPORT
A 50 year old patient presented with a palpable tumor of right parotid gland with involvement of overlying skin and few palpable level I and II cervical lymph nodes. On CT scan the lesion measured 4.3x2.6x5.8 cm in diameter arising from superficial lobe of the right parotid with partial involvement of deep lobe. The lesion also involved overlying skin and level II and III deep cervical lymph nodes however spared the carotid sheath and other vital structures in the vicinity. FNAC of the lesion showed malignant cells with suspicion of mucoepidermoid carcinoma of the parotid gland with radiological staging mounting to T4N2M0. Radical partial conservative parotidectomy with modified radical neck dissection was carried out. The tissue defect was filled with free radial forearm flap. Histopathology showed salivary duct cell carcinoma with free resection margins and 3 out of 45 lymph nodes had metastatic deposits. Patient had postoperative chemo radiation and is recurrence free for last two years.
DISCUSSION
Highly aggressive salivary duct carcinoma of the parotid gland is relatively uncommon tumor. About 200 cases have been reported in the English literature. [1] [2] [3] [4] These tumors exhibit great histological similarities to the invasive duct cell carcinoma of female breast that is why it has been dubbed as "salivary duct carcinoma". 5 Merely 1% to 3% of all malignant salivary gland tumors fall under this category. [1] [2] [3] [4] [5] The parotid gland is most commonly involved. Tumour has got inherent tendency to involve facial nerve and temporal bone via perineural spread. 5 Gingival metastasis has also been reported. 
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Other salivary glands are relatively less likely to be involved. Salivary duct carcinoma may develop ex-pleomorphic and at times denovo. This aggressive tumor involves extreme of age and involves the facial nerve in 40-60% of the cases. Nodal spread has been estimated in 35% of the cases 5 Imaging modalities in form MRI and CT scan are supportive in analyzing local and nodal extension of the tumor. [1] [2] [3] [4] [5] [6] Definitive diagnosis is histological. FNAC may be useful but may not be reliable like in our case; it was reported as mucoepidermoid carcinoma and later was diagnosed as a case of salivary duct cell carcinoma. Gross findings consist of a tumor of variable size with solid and cystic component. Microscopically, the most peculiar feature is the similarity to ductal carcinoma of the breast. The tumor is composed of an intraductal and invasive components. [6] [7] [8] [9] Intraductal component is cribriform, papillary, solid with comedo-like central necrosis. The infiltrative component is made of glands, cords of cells with desmoplastic reaction. Many forms have been described such as sarcomatoid salivary duct carcinoma, low-grade neoplasm, and mucinrich variant. 8 Immunohistochemical findings are not useful, but a constant overexpression of keratin, HER/2 neu, CEA, and c-erd-B2 have been noted. Frequently, androgen receptors and prostate-specific antigen expression have also been reported. The cell proliferation rate (Ki-67) and the overexpression of growth factor-binding receptors like HER2/neu, p16, and p53 have been identified as important factors in the genesis of salivary gland tumors. 8, 9 There is no consensus on the therapeutic approach for such tumors but the surgeons usually agree that the resection should be aggressive. If facial paralysis is present, a radical parotidectomy is procedure of choice. In patients with involvement of the submandibular or minor salivary glands, tumor resection with wide margins of surrounding tissue is indicated to control local disease as the disease appears to be more aggressive. 10 The effects of adjuvant postoperative radiotherapy remain unclear but tumor aggression dictates the use of adjuvant measures. Postoperative radiation therapy appears appropriate in case of extraparotid extension, positive resection margins and cervical lymph node metastasis. Chemotherapy is generally reserved for metastatic forms of the disease. 11 A recent study reported utility of both anti-androgen therapy and chemotherapy for a patient with advanced salivary duct carcinoma. 12 The tumor has bad prognosis and approximately 50% of the patients die within 5 years. Copyright© 20 July, 2016.
